Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses
-
Add time:07/18/2019 Source:sciencedirect.com
The objective was to compare the gastrointestinal and general toxicity of suxibuzone (SBZ) to that of phenylbutazone (PBZ) when administered orally in horses. Fifteen healthy horses were allocated to three treatment groups. One group received a high dose of PBZ for two weeks; the second group was given an equimolecular dosage of SBZ; and a third group received placebo. Horses were daily monitored, and blood samples were collected before and during the study. On day 18, complete post-mortem examinations were performed.One horse treated with PBZ showed clinical signs of NSAID toxicosis. Small oral ulcers were also detected in other two horses from the PBZ group and in two horses from the SBZ group. There were no statistical differences in the blood parameters among groups. Ulcers in the stomach’s glandular mucosa were observed in all horses of the PBZ group, while only two horses of the SBZ group showed ulcerations. PBZ horses had a significant higher ulcerated area, and gastric ulcers were significantly deeper than those in the SBZ and placebo groups. No other lesions were found in any other tissue. In conclusion, SBZ causes significantly lower gastric ulcerogenic effect than PBZ when administered orally at equimolecular doses in horses.
We also recommend Trading Suppliers and Manufacturers of Phenylbutazone calcium (cas 70145-60-7). Pls Click Website Link as below: cas 70145-60-7 suppliers
Prev:Quantitative determination of carbasalate calcium derived metabolites, acetylsalicylic acid and salicylic acid, in six animal foods using liquid-liquid extraction method coupled with liquid chromatography-tandem mass spectrometry
Next:Drug Permeation through Membranes III: Effect of pH and Various Substances on Permeation of Phenylbutazone through Everted Rat Intestine and Polydimethylsiloxane) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The sensitivity of human bone marrow granulocyte/monocyte precursor cells to phenylbutazone, oxyphenbutazone and gamma-hydroxyphenylbutazone in vitro, with observations on the bone marrow colony formation in phenylbutazone-induced granulocytopoenia07/21/2019
- Drug Permeation through Membranes III: Effect of pH and Various Substances on Permeation of Phenylbutazone through Everted Rat Intestine and Polydimethylsiloxane07/19/2019
- Quantitative determination of carbasalate calcium derived metabolites, acetylsalicylic acid and salicylic acid, in six animal foods using liquid-liquid extraction method coupled with liquid chromatography-tandem mass spectrometry07/17/2019
- Effects of phenylbutazone and oxyphenbutazone on acidic drug detection in high performance thin layer chromatographic systems07/16/2019
- Propylene glycol enhances anti-inflammatory effects of phenylbutazone07/15/2019
- DSC study of the action of phenylbutazone on phospholipid phase transitions07/14/2019
- DSC study of the action of phenylbutazone on DMPC and DPPC bilayers07/13/2019
- Comparison of the effect of Sporobolus virginicus and Rhodes (Chloris gayana) hay diets on the absorption pattern of phenylbutazone in the camel (Camelus dromedarius)07/12/2019
-
Health and Chemical more >
-
Related Products
- Calcium valproate
- Calcium (1)-bis(2-hydroxy-4-methylvalerate)
- Calcium (2S)-2-[(4-chlorobenzoyl)amino]-3-(1H-indol-3-yl)propanoate
- Calcium (S)-3-methyl-2-oxovalerate
- Calcium 2,4-dichlorophenolate
- Calcium 2-ethylhexanoate
- Calcium 2-hydroxypropanoate
- Calcium 2-methoxyethoxide
- Calcium 2-oxoglutarate
- Calcium 3-methyl-2-oxovalerate


